SciClone Pharmaceuticals, Inc. Stock

Stocks

17-10-13	SciClone Pharmaceuticals : Consortium Led By GL Capital Completes Acquisition Of SciClone	PR
17-08-29	Levi & Korsinsky, LLP Notifies Shareholders of SciClone Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 30, 2017	BU
17-08-17	Monteverde & Associates PC Announces An Investigation Of SciClone Pharmaceuticals, Inc. - SCLN	PR
17-08-16	SciClone Pharmaceuticals : Breakfast Technical Briefing on Drug Makers Stocks -- Depomed, Synergy Pharma, Novo Nordisk, and SciClone Pharma	PR
17-08-10	SciClone Pharmaceuticals : Announces End Of Go-Shop Period With No Parties Designated As Excluded Parties	PR

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SCICLONE PHARMACEUTICALS, INC.	-.--%	-.--%	-	-	0
ELI LILLY AND COMPANY	+1.86%	+7.65%	+55.77%	+158.84%	1,063B
JOHNSON & JOHNSON	+3.57%	+7.42%	+69.09%	+58.92%	611B
ABBVIE INC.	+3.99%	+7.37%	+36.87%	+93.77%	444B
ROCHE HOLDING AG	-1.20%	-1.94%	+26.41%	+20.22%	324B
ASTRAZENECA PLC	+4.94%	+3.39%	+39.92%	+28.93%	285B
NOVARTIS AG	+2.42%	+1.60%	+30.06%	+42.24%	283B
NOVO NORDISK A/S	+2.47%	+5.18%	-24.80%	-39.60%	219B
AMGEN INC.	+3.55%	+6.05%	+26.04%	+68.52%	195B
GILEAD SCIENCES, INC.	+4.21%	+6.00%	+17.72%	+70.33%	156B
Average	+2.11%	+4.27%	+30.79%	+55.80%	397.85B
Weighted average by Cap.	+1.85%	+5.08%	+41.55%	+80.68%

Employees

Sector